Macrophage M1 is known to be remarkedly connected with anti-tumor effect and better prognosis, which means regulating the expression of APOBEC3A might be an available strategy to change the number of activated immune tumor-infiltrating cells, and thus improve the prognosis and sensitivity of immunotherapy in OC. Here, APOBEC3A is linked to neoplasm.